Pharma Journalist -

Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today the opening of a new research and…
Read More...

Pfizer Inc. announced the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC ODT (rimegepant), an innovative migraine therapy approved…
Read More...

Biogen Inc. and Denali Therapeutics Inc. announced that dosing has commenced in the global Phase 3 LIGHTHOUSE study to evaluate the efficacy and safety profile of BIIB122 (DNL151), as…
Read More...

AmplifyBio, a contract research organization (CRO) focused on accelerating innovation across pharmaceutical modalities; announced the acquisition of select assets from PACT Pharma,…
Read More...

Alexion, AstraZeneca Rare Disease, announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio Therapeutics, Inc., a pioneering genomic medicine…
Read More...

Vanda Pharmaceuticals Inc. (Vanda) and OliPass Corporation (OliPass) announced that they have entered into a research and development collaboration agreement to jointly develop a set of…
Read More...

InflaRx N.V. submitted a request for Emergency Use Authorization (EUA) following encouraging interactions with the US Food and Drug Administration (FDA) at a Type B meeting held this…
Read More...

Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule…
Read More...

Amylyx Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved RELYVRIO™ (sodium phenylbutyrate and taurursodiol) for the treatment of adults with…
Read More...

Myovant Sciences Ltd. confirmed that it has received a preliminary, non-binding proposal from Sumitovant Biopharma Ltd. and Sumitomo Pharma Co., Ltd. to acquire the remaining shares of…
Read More...